Stockscreener 앱 받기
371.87
1.63%
-6.3189
전일 마감가:
$378.19
열려 있는:
$374.08
하루 거래량:
108.11K
Relative Volume:
0.11
시가총액:
$36.52B
수익:
$3.77B
순이익/손실:
$449.25M
주가수익비율:
47.34
EPS:
7.8556
순현금흐름:
$240.68M
1주 성능:
-1.17%
1개월 성능:
+4.21%
6개월 성능:
-3.96%
1년 성능:
+25.30%
1일 변동 폭
$371.34
$378.90
1주일 범위
$368.92
$381.31
52주 변동 폭
$275.05
$414.15
워터스 코퍼레이션 Stock (WAT) Company Profile
명칭
Waters Corp
전화
(508) 478-2000
주소
34 MAPLE ST, MILFORD, MA
Compare WAT vs TMO, DHR, IDXX, NTRA, A
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
WAT
Waters Corp
|
371.90 | 37.13B | 3.77B | 449.25M | 240.68M | 7.8556 |
TMO
Thermo Fisher Scientific Inc
|
533.02 | 201.86B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
203.31 | 145.10B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
567.25 | 45.44B | 4.45B | 1.10B | 1.06B | 13.59 |
NTRA
Natera Inc
|
263.27 | 38.64B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
132.20 | 38.44B | 7.23B | 1.41B | 1.09B | 4.979 |
워터스 코퍼레이션 Stock (WAT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-06 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2026-02-10 | 재개 | Barclays | Overweight |
| 2026-02-10 | 재개 | Citigroup | Buy |
| 2026-02-10 | 재개 | Evercore ISI | In-line |
| 2026-01-06 | 개시 | Guggenheim | Buy |
| 2026-01-05 | 개시 | William Blair | Outperform |
| 2025-12-10 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2025-12-02 | 개시 | Morgan Stanley | Equal-Weight |
| 2025-10-08 | 개시 | Rothschild & Co Redburn | Buy |
| 2025-03-31 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-03-26 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2025-02-13 | 업그레이드 | Scotiabank | Sector Perform → Sector Outperform |
| 2025-02-10 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2025-01-10 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | 개시 | Scotiabank | Sector Perform |
| 2024-10-08 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-08-28 | 개시 | Wells Fargo | Overweight |
| 2024-08-01 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2024-06-03 | 재개 | Jefferies | Hold |
| 2023-11-13 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2023-09-28 | 개시 | Bernstein | Mkt Perform |
| 2023-07-31 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2023-07-31 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2022-12-14 | 개시 | Deutsche Bank | Hold |
| 2022-08-25 | 개시 | Credit Suisse | Neutral |
| 2022-07-20 | 개시 | UBS | Neutral |
| 2022-05-18 | 개시 | Barclays | Overweight |
| 2022-05-17 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2022-04-25 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2021-10-15 | 재개 | Cowen | Market Perform |
| 2021-07-06 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2021-01-07 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2020-12-17 | 업그레이드 | Cleveland Research | Underperform → Buy |
| 2020-12-16 | 업그레이드 | Citigroup | Sell → Neutral |
| 2020-12-02 | 개시 | Goldman | Neutral |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2020-07-28 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2020-07-16 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2020-01-08 | 다운그레이드 | Needham | Hold → Underperform |
| 2020-01-08 | 개시 | Wells Fargo | Underweight |
| 2020-01-07 | 개시 | Citigroup | Sell |
| 2019-11-15 | 개시 | Stifel | Hold |
| 2019-10-09 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2019-07-16 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2019-06-12 | 다운그레이드 | Cleveland Research | Neutral → Underperform |
| 2019-05-30 | 개시 | Wolfe Research | Underperform |
| 2019-01-24 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2019-01-03 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-01-03 | 개시 | Needham | Hold |
| 2018-12-12 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2018-11-30 | 다운그레이드 | Goldman | Neutral → Sell |
| 2018-10-11 | 업그레이드 | Cleveland Research | Sell → Neutral |
모두보기
워터스 코퍼레이션 주식(WAT)의 최신 뉴스
Mass Spectrometry Market Size Worth USD 14.09 Billion by 2035 | SNS Insider - GlobeNewswire Inc.
Waters stock trades steadily as chromatography demand supports revenue growth - ad-hoc-news.de
What Just Happened with BD and Waters - Kavout | AI
Waters Corporation's Quarterly Earnings Preview: What You Need to Know - inkl
Waters Corp stock holds steady as analytical instruments underpin long-term demand - ad-hoc-news.de
Waters Corp. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Waters Corporation (WAT) Gains as RBC Initiates Coverage with Ou - GuruFocus
Waters Corp. Coin Cell DSC: Direct Thermal and Gas Analysis for Battery SafetyNews and Statistics - IndexBox
RBC Capital initiates Waters stock coverage with outperform rating By Investing.com - Investing.com Nigeria
RBC Capital initiates Waters stock coverage with outperform rating - Investing.com
Waters Corp : RBC Initiates Coverage With Out - Moomoo
Waters Corporation outlines its role in analytical science as investors watch long-term growth drive - ad-hoc-news.de
Waters Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
Caribbean Airlines drops Blue Waters from in-flight service - Trinidad Guardian
Waters Corporation business model and stock context for long-term investors - ad-hoc-news.de
The Waters ACQUITY UPLC H-Class PLUS Bio. A quieter upgrade for biopharma labs - ad-hoc-news.de
Waters Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Overcoming Analytical Bottlenecks in Advanced Therapies Development - Technology Networks
Waters Corporation highlights analytical instrumentation strength as a global life sciences supplier - ad-hoc-news.de
Fidelity Mid Cap Value Index Fund's Waters Corp(WAT) Holding History - GuruFocus
WATWaters Corp Options - Finviz
Waters Corporation focuses on analytical instruments as investors watch long-term growth - ad-hoc-news.de
Waters Corporation focuses on analytical science amid steady demand - ad-hoc-news.de
Waters stock tracks its core lab testing business. - Ad Hoc News
[Form 4] WATERS CORP /DE/ Insider Trading Activity - Stock Titan
Waters Corp (WAT) director Wei Jiang granted 67.42 deferred stock units - Stock Titan
Waters Corp explores growth opportunities as demand for analytical instruments stays resilient - ad-hoc-news.de
Waters to hold Q2 2026 results call Aug. 4, webcast set - Stock Titan
Waters Corporation highlights analytical science role amid steady industry demand - ad-hoc-news.de
Waters Corp. stock outperforms competitors on strong trading day - MarketWatch
Waters Corp. stock underperforms Monday when compared to competitors - MarketWatch
Waters Corporation with a clear analyst view, shares trade steadily on the NYSE - ad-hoc-news.de
ACQUITY Premier System from Waters Corpmetal free flow path for tougher separations - ad-hoc-news.de
Waters Corp (WAT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Bernstein SocGen resumes Waters stock coverage with outperform rating - Investing.com UK
Waters (WAT) Receives Outperform Rating with $435 Target from Be - GuruFocus
Bernstein SocGen resumes Waters stock coverage with outperform rating By Investing.com - Investing.com Australia
WAT Reinstated by Bernstein -- Rating Upgraded to Outperform - GuruFocus
Waters Corporation clears a fresh analyst mark, shares trade higher on Xetra and NYSE - AD HOC NEWS
Form 4 Waters Corporation For: 25 June By Investing.com - Investing.com Australia
Waters (NYSE: WAT) SVP has 189 shares withheld to cover RSU tax - Stock Titan
SNT Biotech Announces a Partnership with Waters Corporation to Bring the Most Comprehensive FDA-Cleared At-Home HPV Cervical Cancer Screening Tool Available in the U.S. Today to Patients - The AI Journal
Waters, IMU Biosciences partner to accelerate AI immune mapping for precision medicineVietnam Investment Review - Vietnam Investment Review - VIR
Waters Corp (WAT) Stock Up 3.4% and Still Undervalued -- GF Scor - GuruFocus
Waters Corp. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
IMU Biosciences, Waters form AI immunology partnership - Investing.com
Waters backs IMU’s AI blood test platform for cancer and other diseases - Stock Titan
Waters Corporation (WAT): Buy, Sell, or Hold Post Q1 Earnings? - Yahoo Finance
Waters Corp (WAT) Valuation: PE, PB & Fair Value Analysis - TradingKey
Waters Corp (WAT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Waters opens the week with earnings focus, shares on NYSE - ad-hoc-news.de
워터스 코퍼레이션 (WAT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.76%
0.32%
자본화:
|
볼륨(24시간):